OTCPicks Featured Company: SyntheMed, Inc. (SYMD.OB) Core Product is Approved in Canada
SyntheMed, Inc. (OTCBB: SYMD), a biomaterials company engaged in the development and commercialization of medical devices for therapeutic applications, recently announced that their bioresorbable adhesion barrier film for reduction of adhesions following cardiac surgery, REPEL-CV®, received approval from Health Canada to be used in pediatric patients who undergo open heart surgery. The Montreal based distributor of cardiac surgery products, Force3 Medicale, Inc., will be responsible for the marketing of REPEL-CV. SyntheMed's Vice President, Marc Sportsman, said, "We are pleased to receive the Health Canada approval which allows us to further expand the international distribution of REPEL-CV." The company offers products…